This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Nu Skin (NUS) Tops Q2 Earnings and Sales, Currency a Woe
by Zacks Equity Research
Nu Skin's (NUS) top line declined primarily due to negative impacts of currency fluctuations and dismal regional revenues.
Molson Coors (TAP) Q2 Earnings Lag, Currency Plays Spoilsport
by Zacks Equity Research
Molson Coors (TAP) sales gained from strong growth in Europe and International regions owing to the addition of Miller global brands business. However, currency dented company's earnings in the second quarter.
Stericycle (SRCL) to Report Q2 Earnings: What Lies Ahead?
by Zacks Equity Research
Focus on increasing operational efficiency and continuous investments in data analytic capabilities to improve its performance are likely to drive Stericycle's (SRCL) Q2 earnings.
Diageo (DEO) FY17 Earnings: Sales and Productivity Go Up
by Zacks Equity Research
Diageo's (DEO) organic net sales grew across all its segments owing to improved operating efficiency and productivity initiatives.
Is Church & Dwight (CHD) Poised for a Beat in Q2 Earnings?
by Zacks Equity Research
Church & Dwight (CHD) is likely to offset headwinds on the back of a stable portfolio of value and premium products, aggressive acquisitions and productivity programs and tight management of overhead expenses in Q2.
What's in Store for Treehouse Foods (THS) in Q2 Earnings?
by Zacks Equity Research
Treehouse Foods (THS) has been battling rising cost of operations and changing consumer preferences, which are expected to hurt second-quarter results.
Pilgrim's Pride (PPC) Q2 Earnings: What's in the Cards?
by Zacks Equity Research
Pilgrim's Pride's (PPC) Q2 results will likely gain traction from the Newport buyout and solid demand. However, persistent headwinds in the industry remain key concerns.
Is a Beat in Store for Nu Skin (NUS) this Earnings Season?
by Zacks Equity Research
Nu Skin (NUS) has been exhibiting robust growth in its ageLOC Me and ageLOC Youth products, which has encouraged management to continue with its innovation and product launches.
Is Nu Skin Enterprises (NUS) a Great Stock for Value Investors?
by Zacks Equity Research
Is Nu Skin Enterprises a great pick from the value investor's perspective right now? Read on to know more.
Avon (AVP) Delivers Q1 Loss, Transformation Plan Looks Good
by Zacks Equity Research
Avon Products Inc. (AVP) posted adjusted loss from continuing operations of 7 cents per share for first-quarter 2017, lagging the Zacks Consensus Estimate of break-even.
Are Options Traders Betting on a Big Move in Nu Skin Enterprises (NUS) Stock?
by Zacks Equity Research
Nu Skin Enterprises (NUS) warrants investors' attention based on moves in the options market lately.
Estee Lauder (EL) Stock Up on Q3 Earnings, Sales Beat
by Zacks Equity Research
Estee Lauder Companies Inc. (EL) continues to impress investors with better-than-expected earnings for the eleventh consecutive quarter, when the company reported third-quarter fiscal 2017 results.
Can Nu Skin (NUS) Spring a Surprise This Earnings Season?
by Zacks Equity Research
Nu Skin (NUS) is all set to report first-quarter 2017 results on May 3, after the closing bell.
Nu Skin Enterprises (NUS) Appoints New Managerial Positions
by Zacks Equity Research
Nu Skin Enterprises Inc. (NUS) has recently appointed Mark H. Lawrence as its new chief financial officer (CFO), who will take position from Mar 27. Lawrence will succeed Ritch Wood, who will now be the company's chief executive officer (CEO), as announced in Dec 2016.
Consumer Staples Stock Earnings on Feb 16: AVP, NUS & ELF
by Zacks Equity Research
Let's take a look at what's in store for the following consumer staples stocks which are likely to release their fourth-quarter 2016 results on Feb 16.
Nu Skin (NUS) Q4 Earnings: Disappointment in the Cards? (revised)
by Zacks Equity Research
Despite the positives, the company faces several regulatory issues.
Nu Skin (NUS) Q4 Earnings: Disappointment in the Cards?
by Zacks Equity Research
Nu-Skin Enterprises, Inc. (NUS) is set to report fourth-quarter 2016 results on Feb 13, after the market closes. The question lingering in investors' minds is, whether the company will be able to deliver a positive earnings surprise in the to-be-reported quarter.
Can Nu Skin Be a Solid Choice for Value Investors?
by Zacks Equity Research
Let's see if company Nu Skin Enterprises Inc. (NUS) stock is a good choice for value-oriented investors right now from multiple angles
Nu Skin (NUS) Provides Weak 2016 Sales View; CEO to Exit
by Zacks Equity Research
Nu Skin Enterprises Inc. (NUS) recently updated its financial guidance for 2016, wherein it expects sluggish sales growth and also announced the exit of its Chief Executive Officer ("CEO"). Shares of Nu Skin declined 7.2% yesterday after the news. The company also provided an initial guidance for 2017.
New Strong Buy Stocks for September 26th
by Indradip Ghosh
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Monday
New Strong Buy Stocks for September 1st
by Indradip Ghosh
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Thursday
New Strong Buy Stocks for August 19th
by Indradip Ghosh
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Friday
Bear of the Day: Nu Skin (NUS)
by Kevin Cook
Earnings estimates continue to peel away for this network marketer
Bear of the Day: Nu Skin (NUS)
by Kevin Cook
The persistent earnings evaporation here was caught perfectly all year by the Zacks Rank